BIBLIOGRAFIA - Atrofia Muscolare Spinale (SMA)

  1. Linee guida per la riabilitazione delle malattie neuromuscolari infantili di origine genetica. G di Neuropsicofarmacol.
  2. Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care-NC-ND license. Neuromuscul Disord. 2018;
  3. Il- EB V, Th M. Dossier Spinraza Piemonte. 2017.
  4. Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018 Mar 1;
  5. Sumner CJ, Paushkin S, Ko C. Spinal muscular atrophy : disease mechanisms and therapy.
  6. D’Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Vol. 6, Orphanet journal of rare diseases. BioMed Central; 2011. 71 p.
  7. Arnold ES, Fischbeck KH. Spinal muscular atrophy. Handb Clin Neurol. 2018;591–601.
  8. Riassunto delle caratteristiche del prodotto. Epidemiol Psichiatr Soc.
  9. SMA, risultati clinici incoraggianti da olesoxime - Osservatorio Malattie Rare.
  10. Messina S. New Directions for SMA Therapy. J Clin Med. 2018 Aug 31;
  11. Prakash V. Spinraza-a rare disease success story. Gene Ther. 2017 Sep;
  12. Gidaro T, Servais L. Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps. Dev Med Child Neurol. 2019;
  13. Mastella C, Ottonello G. “SMA1 abita con noi”. Vademecum per una sostenibile vita quotidiana a casa. 2009.
  14. Smartnet P. HFMSE Manual. 2009.
  15. De Sanctis R, Coratti G, Pasternak A, Montes J, Pane M, Mazzone ES, et al. Developmental milestones in type I spinal muscular atrophy. Neuromuscul Disord. 2016;26:754–9.
  16. Glanzman AM et A. Chop Intend manuale. Medicina. 2010.
  17. Evaluator LC. Revised Upper Limb Module for SMA. 2014;1–21.
  18. Bérard C, Payan C, Hodgkinson I, Fermanian J. A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15:463–70.